RNAi Therapeutics Market growth is benefiting from ongoing clinical research evaluating RNA interference medicines for different genetic and acquired diseases.
The RNAi Therapeutics Market was valued at US$ 1.5 billion in 2021 and is projected to reach US$ 3.2 billion by 2031, registering a CAGR of 16.5% during the forecast period from 2023 to 2031. Market growth is supported by advances in...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek